The Effects of Intraocular Pressure-Lowering Drops on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager
Diagnostics · 13.05.2026 · 16 (10) · 1482
DOI: 10.3390/diagnostics16101482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.05.2026. Verfasst von Alice Verticchio Vercellin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NYEE Foundation, Ministry of Health, Fondazione Roma.
Abstract (Originalsprache)
Background/Objectives: The aim of this study was to investigate the effects of intraocular pressure (IOP)-lowering drops on the sublayers of the human tear film as assessed by a novel nanometer-resolution Tear Film Imager (TFI, AdOM, Israel).
Methods
In a prospective, cross-sectional study, 98 eyes from 56 adult human subjects were imaged using the TFI. The dataset included data from 18 eyes from 12 subjects treated with preserved IOP-lowering drops and 80 eyes from 44 control subjects not under ocular hypotensive therapy. Subjects in the IOP treatment group used a variety of IOP-lowering medications, including prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, alpha agonists, and combination drops. A linear mixed effects model was used to assess the association between IOP-lowering therapy and tear film (TF) metrics, controlling for age and intra-individual correlation. The following parameters were measured: muco-aqueous layer thickness (MALT), muco-aqueous layer thinning rate (MALTR), lipid layer thickness (LLT), lipid map uniformity (LMU), inter-blink intervals (IBI), and lipid break-up time (LBUT).
Results
Average ages significantly differed (p = 0.013) between the treatment group (66.5 years) and control group (average age 51.5 years), and thus results were adjusted for age accordingly. IOP was 17.1 mmHg in the treatment group and 16.1 mmHg in the control group. When analyzing the sublayers of the TF, MALTR had a significant association with IOP-lowering therapy after adjusting for age, with a difference of −52.68 nm/s; 95% confidence interval [−96.87, −8.48]; p-value = 0.020. Additionally, IBI was significantly associated with IOP-lowering therapy after log transformation (p = 0.049), with shorter IBI in the treatment group. All other metrics (MALT, LLT, LMU, and LBUT) were statistically insignificant (p > 0.05).
Conclusions
These pilot results suggest that IOP-lowering drops may accelerate thinning of the TF, specifically the muco-aqueous layer. Longitudinal studies with significantly larger samples are needed to specify the differential impact of various ocular hypotensive therapies on the human TF and the clinical implications of these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY 10003, USA.
- AdOM Advanced Optical Technologies Ltd., Lod 71520, Israel.
- Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Department of Biostatistics and Health Data Science, Indiana University School of Medicine and Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA.
ORCID-Profile: Samuel Potash, Paul A Sidoti, Norman J Kleiman, George J Eckert, Carmela Carnevale, Minwoo Kwon, Gal Antman
Förderung
- NYEE Foundation
- Ministry of Health
- Fondazione Roma
Zitieren
APA
Verticchio Vercellin, A., Potash, S., Manusis, K., Sidoti, P. A., Rosen, R. B., Siesky, B. A., Wood, K., Greenberg, L. A., D'Amelia, P., Kenig, E., Kleiman, N. J., Brenner, D. J., Eckert, G. J., Tanga, L., Carnevale, C., Chen, M., Qi, D., Kwon, M., & Antman, G. (2026). The Effects of Intraocular Pressure-Lowering Drops on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager. Diagnostics, 16(10), 1482. https://doi.org/10.3390/diagnostics16101482
Vancouver
Verticchio Vercellin A, Potash S, Manusis K, Sidoti PA, Rosen RB, Siesky BA, et al. The Effects of Intraocular Pressure-Lowering Drops on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager. Diagnostics. 2026;16(10):1482. doi:10.3390/diagnostics16101482
BibTeX
@article{VerticchioVercellin2026,
author = {Verticchio Vercellin, Alice and Potash, Samuel and Manusis, Kira and Sidoti, Paul A and Rosen, Richard B and Siesky, Brent A and Wood, Keren and Greenberg, Lily A and D'Amelia, Peter and Kenig, Edan and Kleiman, Norman J and Brenner, David J and Eckert, George J and Tanga, Lucia and Carnevale, Carmela and Chen, Masako and Qi, David and Kwon, Minwoo and Antman, Gal},
title = {The Effects of Intraocular Pressure-Lowering Drops on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {10},
pages = {1482},
doi = {10.3390/diagnostics16101482}
}
EUVIMED